NEW YORK — Patterson Belknap Webb and Tyler LLP introduced the launch of Misbranded, a blog masking false commercials litigation from the industry perspective, with an emphasis on FDA regulated items: foods/drinks, pharmaceuticals, cosmetics, and dietary dietary supplements. Located at misbrandedblog. com, the blog will deliver timely updates on vital new cases, surveys of litigation trends, and in depth analyses of “hot” legal issues. Initial blog posts come with analyses of injury modeling options in false advertisements class actions; the role of the FDA mandated factor list in customer litigation; the impact of recent First Amendment decisions on advertisers’ duty to expose; and the provision of indemnity and contribution for inadvertent false ads.
Blog content may be authored by Patterson Belknap’s preeminent False Advertising apply group, which pioneered modern false ads litigation in the 1970s, and whose contributors have represented companies as both plaintiffs and defendants in lots of of probably the most tremendous false advertisements cases of the past four decades. Chambers and Partners lists Patterson Belknap as one of only three “Band 1” firms in the USA for ads litigation. The blog will be edited by Patterson Belknap litigation partners Steven A. Zalesin, Jonah M. Knobler, Joshua Kipnees, and Jane Metcalf, a team with extensive event representing global and national brands in novel and high stakes false ads litigation.